India Aurobindo gets tentative FDA nod for quinapril
India Aurobindo gets tentative FDA nod for quinapril
Mumbai: India’s Aurobindo Pharma Ltd. has received tentative approval for quinapril hydrochloride and hydrochlorothiazide tablets from the US Food and Drug Administration, the regulator’s Web site showed.
The drugs, used in treating hypertension and congestive heart failure, are the generic equivalents of Pfizer Inc.’s Accupril and Accuretic tablets.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!